Ann: USA FDA Grants Orphan Drug Status for PAT-SM, page-58

re: Ann: USA FDA Grants Orphan Drug Status fo... Onshow, This is a comment we should analyse.

If you go back, in April Patrys did the same thing, news on the cohort 2 moved up on big volumes, same trading pattern.

Fund had sold due to the fund focusing in other areas.

Then the market knew that no news flow till July/August and again stale money coming out.

Then the talk of further funding saw the short terms out.

This Company is aligned to be very big, very soon, I think.

They have an excellent board starting with Marie very focused and a realist! Suzy as the deal maker I think, check her background, Michael as their backer with big connections!

As you can see, if you have followed Patrys they have aligned many investors as you will see from the last presentations that were put out by Marie in the last few months.

I was present at the AGM, where I met all of the board, I especially found speaking to Michael Stork very interesting, he was very relaxed about his investment in Patrys, if you have been following Patrys you will know that he has over 20m invested in this stock.

I feel that fresh money has come into Patrys, on the exposure that Marie has presented in the USA. This stock is difficult to follow on a chart, but each time this has happened the stock has reversed on the news day and then the next day has gone on with it.

Just remember there are still imminent results due from cohort 4, and Marie has said in her reports that they are speaking with many people.

Please DYOR....